Nitrates and Nitrite Compounds

Organic nitrates and nitrites are vasodilator drugs that act as exogenous donors of nitric oxide. After bioactivation in vascular tissue they release nitric oxide, which stimulates soluble guanylyl cyclase to raise cyclic GMP and relax vascular smooth muscle — predominantly in veins at usual exposures, reducing cardiac preload and relieving the myocardial ischaemia of angina.

Definition

Nitrates and nitrite compounds are nitric-oxide-donor vasodilators that, after enzymatic or non-enzymatic bioactivation, release nitric oxide to activate soluble guanylyl cyclase, increase cyclic GMP, and relax vascular smooth muscle, producing venodilation and coronary vasodilation.

Scope

The topic covers the bioactivation and nitric-oxide / cyclic-GMP mechanism of organic nitrates, their haemodynamic effects, the problem of nitrate tolerance, and their place among cardiovascular vasodilators. It is a pharmacological reference and offers no dosing or individualized treatment guidance.

Core questions

• How are organic nitrates bioactivated to release nitric oxide?
• How does the nitric-oxide / cyclic-GMP pathway relax vascular smooth muscle?
• Why does continuous nitrate exposure produce tolerance?
• What is the haemodynamic basis for nitrate relief of angina?

Key concepts

• Nitric oxide donation
• Bioactivation of organic nitrates
• Soluble guanylyl cyclase and cyclic GMP
• Venodilation and preload reduction
• Coronary vasodilation
• Nitrate tolerance and nitrate-free intervals

Key theories

Nitric-oxide / cyclic-GMP vasodilation

Nitric oxide, the molecule responsible for endothelium-derived relaxing factor activity, activates soluble guanylyl cyclase in vascular smooth muscle to raise cyclic GMP, which lowers intracellular calcium and produces relaxation; organic nitrates exploit this pathway by acting as exogenous nitric-oxide donors.

Mechanisms

Organic nitrates such as nitroglycerin are prodrugs that undergo bioactivation in vascular smooth muscle — mitochondrial aldehyde dehydrogenase contributes to this step for nitroglycerin — releasing nitric oxide or a related species. Nitric oxide, identified as the carrier of endothelium-derived relaxing factor activity, stimulates soluble guanylyl cyclase to raise cyclic GMP; cyclic GMP activates protein kinase G, lowers cytosolic calcium, and relaxes smooth muscle. The predominant venodilation at usual exposures reduces preload and ventricular wall stress, lowering myocardial oxygen demand, while coronary vasodilation can improve supply. Continuous exposure blunts the response (tolerance), attributed in part to impaired bioactivation and increased oxidative stress involving the same enzymatic machinery, which is why nitrate-free intervals are used.

Clinical relevance

Nitrates are long-established agents for the symptomatic relief of angina and have a role in acute heart-failure and pulmonary-congestion management as preload-reducing vasodilators. This entry describes their mechanism and haemodynamic effects for educational reference; it is not a basis for prescribing, scheduling, or combining these drugs in an individual patient.

Epidemiology

Organic nitrates remain widely used for symptomatic relief rather than for mortality reduction, and contemporary guidelines position them among anti-anginal and vasodilator options. Their main practical limitation at the population level is the development of tolerance with continuous use, managed by dosing schedules that allow nitrate-free intervals.

History

Amyl nitrite and nitroglycerin entered clinical use for angina in the nineteenth century, long before their mechanism was understood. The molecular basis emerged in the late twentieth century with the identification of endothelium-derived relaxing factor as nitric oxide and the elucidation of the nitric-oxide / cyclic-GMP signalling pathway — work recognized by the 1998 Nobel Prize — which reframed organic nitrates as exogenous nitric-oxide donors and clarified the basis of nitrate tolerance.

Debates

What is the mechanism of nitrate tolerance and how is it best mitigated?

Continuous nitrate exposure attenuates the vasodilator response through impaired bioactivation and oxidative stress; the relative contributions of these processes, and the best strategies to preserve efficacy, remain areas of investigation.

Key figures

• Salvador Moncada
• Robert Furchgott
• Ferid Murad
• Louis Ignarro
• Thomas Münzel

Seminal works

• palmer-1987

Frequently asked questions

Why are organic nitrates called nitric-oxide donors?

After bioactivation in vascular tissue they release nitric oxide (or a related species), which is the same signalling molecule that endothelium produces to relax blood vessels; the drugs supply this molecule exogenously.

Why does continuous nitrate use lose effectiveness?

Sustained exposure produces tolerance, attributed to impaired bioactivation and increased oxidative stress, which is why dosing regimens often include a nitrate-free interval to restore responsiveness.